Similar articles

• Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.

  Bergqvist D. Bergqvist D. Acta Chir Scand Suppl. 1988;543:87-9. Acta Chir Scand Suppl. 1988. PMID: 2847463 Review. No abstract available.
• A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.

  Hull R, Raskob G, Pineo G, Rosenbloom D, Evans W, Mallory T, Anquist K, Smith F, Hughes G, Green D, et al. Hull R, et al. N Engl J Med. 1993 Nov 4;329(19):1370-6. doi: 10.1056/NEJM199311043291902. N Engl J Med. 1993. PMID: 8413432 Clinical Trial.
• [Effectiveness and safety of low-molecular-weight heparins in prevention of thrombosis].

  Nguyen HN, Matern S. Nguyen HN, et al. Dtsch Med Wochenschr. 2000 Dec 15;125(50):1550-1. doi: 10.1055/s-2000-9470. Dtsch Med Wochenschr. 2000. PMID: 11190768 German. No abstract available.
• Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

  Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD. Leyvraz PF, et al. BMJ. 1991 Sep 7;303(6802):543-8. doi: 10.1136/bmj.303.6802.543. BMJ. 1991. PMID: 1655136 Free PMC article. Clinical Trial.
• Can the bleeding potential of low molecular weight heparins be assessed and minimized in postsurgery prophylaxis?

  Toulemonde F. Toulemonde F. Semin Thromb Hemost. 1991 Oct;17(4):351-5. doi: 10.1055/s-2007-1002634. Semin Thromb Hemost. 1991. PMID: 1666455 Review. No abstract available.